Oliver G. Ottmann
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Journal: Hematology. American Society of Hematology. Education Program
Published: December 17, 2009
First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults.
Journal: Current opinion in oncology
Published: June 30, 2009
Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
Journal: Seminars in hematology
Published: July 17, 2007
Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
Journal: Cancer
Published: April 13, 2007
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal: Hematology. American Society of Hematology. Education Program
Published: November 24, 2005
Development of hygromas or severe edema during treatment with the tyrosine kinase inhibitor STI571 is not associated with platelet-derived growth factor receptor (PDGFR) gene polymorphisms.
Journal: Leukemia research
Published: March 01, 2004
Imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia: current status and evolving concepts.
Journal: Best practice & research. Clinical haematology
Published: March 06, 2003
Therapy of Philadelphia chromosome positive acute lymphatic leukemia (Ph+ ALL) with an inhibitor of abl-tyrosine kinase (Glivec)
Journal: Medizinische Klinik (Munich, Germany : 1983)
Published: February 08, 2002
Growth factors in the treatment of acute lymphoblastic leukemia.
Journal: Leukemia research
Published: January 28, 1999
Showing 1-11 of 11
Last Updated: 09/26/2026